The Latest Breaking News from Vaccine

Pfizer (NYSE:PFE) announced positive top-line data from the Phase 3 clinical trial RENOIR investigating its bivalent RSV prefusion F vaccine candidate, RSVpreF, when administered to adults 60 years of age or older. Pfizer, Inc. shares traded in a range of $47.27 to $47.95 on day volume of 14.45 million shares, closed…

Anti-lockdown advocates have been claiming online this week that Victoria's Chief Health Officer Brett Sutton admitted that vaccines never worked. But that's not what he said.

NEW YORK — Novak Djokovic’s refusal to get the COVID-19 vaccine has seemingly cost him another shot at a tournament.

From next week people in Ireland who are at high risk of getting monkeypox will be offered a dose.

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but how much will they help

Intensive ABC drive to be launched across State

Serbian tennis star, who also missed Australian Open this year, says he will keep in ‘good shape and positive spirit’.

Djokovic had hoped for a change in the rules ahead of the tournament but will now miss his second grand slam of the season

The rollout in Ireland has previously been criticised for being too slow

Over 200 Lanarkshire residents have already been vaccinated

The number of monkeypox cases reported globally dropped by 21% in the last week, reversing a month-long trend of rising infections in a possible sign the outbreak may be starting to decline in Europe, according to an report issued by the World Health Organization on Thursday